The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate
- 1 August 1985
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 60 (4), 695-704
- https://doi.org/10.1111/j.1365-2141.1985.tb07474.x
Abstract
The effects of standard heparin, 3 low MW derivatives of heparin, dermatan sulfate and pentosan polysulfate on the intrinsic coagulation pathway were compared to evaluate the contributions of the anti-factor Xa and anti-thrombin activities to their anticoagulant activities. The anticoagulant potency was measured by the ability of each sulfated polysaccharide to inhibit the generation of thrombin activity in plasma. Similarly, the ability of the 6 sulfated polysaccharides to enhance the rates of inactivation either factor Xa or thrombin in defibrinated plasma containing CaCl and cephalin were also determined. Standard heparin was the only sulfated polysaccharide that could equally inhibit thrombin generation and enhance the inactivation of factor Xa and thrombin by plasma. Dermatan sulfate and pentosan polysulfate were more effective as inhibitors of thrombin generation than potentiators of factor Xa inactivation. Th 2 smallest derivatives of heparin, which had high anti-factor Xa (but low antithrombin) activity, were the poorest inhibitors of thrombin generation. Only sulfated polysaccharides that enhance the inactivation of thrombin by plasma and/or inhibit the generation of thrombin activity in plasma are good anticoagulants. These 2 activities of sulfated polysaccharides appear to be good predictors of the relative antithrombotic potency in vivo.This publication has 26 references indexed in Scilit:
- The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factorBritish Journal of Haematology, 1984
- Low-affinity heparin potentiates the action of high-affinity heparin oligosaccharidesThrombosis Research, 1984
- Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasmaThrombosis Research, 1982
- Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fractionThrombosis Research, 1982
- Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis.BMJ, 1982
- Activation of factor X and prothrombin in antithrombin-III depleted plasma: The effects of heparinThrombosis Research, 1981
- Comparison of the inhibition of thrombin by three plasma protease inhibitorsBiochemistry, 1978
- HÆMORRHAGIC COMPLICATIONS OF HEPARIN THERAPYThe Lancet, 1977
- Partial Purification of Plasma Thromboplastin Antecedent (Factor XI) and its Activation by TrypsinJournal of Clinical Investigation, 1973
- A Brain Extract as a Substitute for Platelet Suspensions in the Thromboplastin Generation TestNature, 1954